Fundraising FoxDSW Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Dia Beta Labs is a drug discovery and development company focused on diabetes and obesity research.
BiotechDigital HealthHealthtechLongevityMedical DevicesBelfast, GB
Dr. Ryan Lafferty(Founder, CEO)Prof. Peter Simpson(Executive Chair, Co-Founder)Prof. Nigel Irwin(Academic Director, Co-Founder)Prof. Peter Flatt(Scientific Committee, Co-Founder)Prof. Finbarr O'Harte(Scientific Committee, Co-Founder)Prof. Victor Gault(Scientific Committee, Co-Founder)
Co-investorsQUBISClarendon Fund Managers Ltd.Innovate UKInnovation UlsterInvest Northern Ireland
Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs.
AI & Machine LearningBiotechDeep TechHealthtech
Dr John Foerster(Scientific Founder)Jamie Hodgson(Chief Executive Officer)in
Co-investorsScottish Enterprise
Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine.
BiotechHealthtechLongevity
Dr. David Kuntin(Chief Executive Officer)Prof. Paul Genever(Chief Scientific Officer)inAnita Adams(Finance Director)in
BoardDr. David Simpson(Chair)Jason Goldstein(Director)
Co-investorsInnovate UK
Manchester-based subscription market research and insights platform focused on the kids, parents and under-30s market.
Co-investorsBusiness Growth Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.